Continuing Education Course #2: Current Understanding of Hemostasis
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The goal of this review is to briefly summarize the two primary pathways of hemostasis, primary hemostasis and secondary hemostasis, as well as to summarize anticoagulant mechanisms and fibrinolysis. In addition, this review will discuss pathologies of hemostasis and the mechanisms of the various drugs that are available to impact these pathways to prevent either thrombosis or bleeding. While many of the main drugs that are used to treat disorders of hemostasis have been used for decades, greater understanding of hemostasis has led to development of various new drugs that have come onto the market recently or are close to coming onto the market. Thus, improved understanding of hemostasis continues to lead to benefits for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
A Cell-based Model of Hemostasis
Monroe, D., & Hoffman, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615947 · Cited by 1,542
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
The hemophilias--from royal genes to gene therapy
Mannucci, P. M., & Tuddenham, E. G. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442307 · Cited by 1,110 · cited 2×
“Depending on the mutation, hemophilia can be severe (<1% function), moderate (1–5%), or mild (5–20%) (Mannucci and Tuddenham 2001).”
BackgroundInherited Antithrombin Deficiency Causing Thrombophilia
Egeberg, O. (1965) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656297 · Cited by 1,030
Structural Basis of Collagen Recognition by Integrin α2β1
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Liddington, R. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80622-4 · Cited by 1,005
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
Surface-dependent reactions of the vitamin K-dependent enzyme complexes
Mann, K., Nesheim, M., Church, W., Haley, P., & Krishnaswamy, S. (1990) · Blood · doi:10.1182/blood.v76.1.1.1 · Cited by 879
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics
Xiao, T., Takagi, J., Coller, B. S., Wang, J.-H., & Springer, T. A. (2004) · Nature · doi:10.1038/nature02976 · Cited by 846
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.
Esmon, C. T., & Owen, W. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2249 · Cited by 830
Adhesion Mechanisms in Platelet Function
Ruggeri, Z. M., & Mendolicchio, G. L. (2007) · Circulation Research · doi:10.1161/01.res.0000267878.97021.ab · Cited by 755
Simon, T. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41091177.x · Cited by 740
The growing complexity of platelet aggregation
Jackson, S. P. (2007) · Blood · doi:10.1182/blood-2006-12-027698 · Cited by 737
Laminin receptor on platelets is the integrin VLA-6
Sonnenberg, A., Modderman, P. W., & Hogervorst, F. (1988) · Nature · doi:10.1038/336487a0 · Cited by 672
Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C., & Furie, B. (2002) · Nature Medicine · doi:10.1038/nm782 · Cited by 669
Dahlbäck, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02225-x · Cited by 610
Cell Adhesion Mechanisms in Platelets
Varga-Szabo, D., Pleines, I., & Nieswandt, B. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150474 · Cited by 588
Inhibition of platelet prostaglandin synthetase by oral aspirin.
Burch, J. W., Stanford, N., & Majerus, P. W. (1978) · Journal of Clinical Investigation · doi:10.1172/jci108941 · Cited by 558
Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen
Nieswandt, B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2120 · Cited by 548
Anticoagulant Action of Heparin
DAMUS, P. S., HICKS, M., & ROSENBERG, R. D. (1973) · Nature · doi:10.1038/246355a0 · Cited by 547
Broze, G. J., Warren, L., Novotny, W., Higuchi, D., Girard, J., & Miletich, J. (1988) · Blood · doi:10.1182/blood.v71.2.335.335 · Cited by 485
Regulation of activated protein C by a new protein. A possible function for bovine protein S.
Walker, F. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70660-7 · Cited by 470
The role of von Willebrand factor in thrombus formation
Ruggeri, Z. M. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.03.011 · Cited by 355
Serpins in thrombosis, hemostasis and fibrinolysis
RAU, J. C., BEAULIEU, L. M., HUNTINGTON, J. A., & CHURCH, F. C. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02516.x · Cited by 347
Kehrel, B., Wierwille, S., Clemetson, K. J., Anders, O., Steiner, M., Graham Knight, C., Farndale, R. W., Okuma, M., & Barnes, M. J. (1998) · Blood · doi:10.1182/blood.v91.2.491 · Cited by 317
Lane, D. A., Philippou, H., & Huntington, J. A. (2005) · Blood · doi:10.1182/blood-2005-04-1710 · Cited by 307
Shen, L., & Dahlbäck, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32228-7 · Cited by 304
Fulcher, C., Gardiner, J., Griffin, J., & Zimmerman, T. (1984) · Blood · doi:10.1182/blood.v63.2.486.486 · Cited by 301
Integrin structures and conformational signaling
Luo, B.-H., & Springer, T. A. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.005 · Cited by 295
Molecular basis of vitamin K-dependent gamma-carboxylation
Furie, B., & Furie, B. (1990) · Blood · doi:10.1182/blood.v75.9.1753.1753 · Cited by 285
Yago, T., Lou, J., Wu, T., Yang, J., Miner, J. J., Coburn, L., López, J. A., Cruz, M. A., Dong, J.-F., McIntire, L. V., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35754 · Cited by 280
Characterization of the protein Z–dependent protease inhibitor
Han, X., Fiehler, R., & Broze, G. J. (2000) · Blood · doi:10.1182/blood.v96.9.3049 · Cited by 184
Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
TERRAUBE, V., O’DONNELL, J. S., & JENKINS, P. V. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02005.x · Cited by 176
Back to the future: a recent history of haemophilia treatment
MANNUCCI, P. M. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01708.x · Cited by 175
Schulze, H., & Shivdasani, R. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01426.x · Cited by 168
Mills, D. C. B. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650674 · Cited by 163
Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles
Tangelder, G. J., Slaaf, D. W., Arts, T. G. J., & Reneman, R. S. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.254.6.h1059 · Cited by 148
Wuillemin, W. A., Minnema, M. C., Meijers, J. C. M., Roem, D., Eerenberg, A. J. M., Nuijens, J. H., Cate, H. T., & Hack, C. E. (1995) · Blood · doi:10.1182/blood.v85.6.1517.bloodjournal8561517 · Cited by 143
Pipe, S. W. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-10-0593 · Cited by 118
Isolation and Characterization of a Platelet Membrane Protein Related to the Vitronectin Receptor
Lam, S. C., Plow, E. F., D'Souza, S. E., Cheresh, D. A., Frelinger, A. L., & Ginsberg, M. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84912-8 · Cited by 105
How I treat von Willebrand disease
Rodeghiero, F., Castaman, G., & Tosetto, A. (2009) · Blood · doi:10.1182/blood-2009-01-153296 · Cited by 88
Venous and arterial thrombosis: Different sides of the same coin?
Franchini, M., & Mannucci, P. M. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.10.019 · Cited by 86
Perzborn, E., Heitmeier, S., von Degenfeld, G., Dittrich‐Wengenroth, E., Buchmüller, A., Gerdes, C., Misselwitz, F., & Laux, V. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0134 · Cited by 67
Furie, B. (2009) · Hematology · doi:10.1182/asheducation-2009.1.255 · Cited by 60
Cohen, M. C. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22021 · Cited by 29
Molecular and cellular basis of fibrinolysis
LIJNEN, H. R., & Collen, D. (1995) · Cited by 28
Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke
Weber, R., Weimar, C., & Diener, H. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903048934 · Cited by 17
Hereditary Disorders of Platelet Function
Rendu, F., & Dupuy, É. (1991) · Blood cell biochemistry · doi:10.1007/978-1-4757-9531-8_4 · Cited by 11
Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists
Giossi, A., Pezzini, A., Zotto, E. D., Volonghi, I., Costa, P., Ferrari, D., & Padovani, A. (2010) · Current Drug Targets · doi:10.2174/138945010790711987 · Cited by 11
Cited by
Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding
Hickman, D. A., Pawlowski, C. L., Sekhon, U. D. S., Marks, J., & Gupta, A. S. (2018) · Advanced Materials · doi:10.1002/adma.201700859 · Cited by 583
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
Chronic Diabetic Wounds and Their Treatment with Skin Substitutes
Holl, J., Kowalewski, C., Zimek, Z., Fiedor, P., Kaminski, A., Oldak, T., Moniuszko, M., & Eljaszewicz, A. (2021) · Cells · doi:10.3390/cells10030655 · Cited by 351
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms
Loo, J., Spittle, D. A., & Newnham, M. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216243 · Cited by 341
Eble, J. A. (2019) · Toxins · doi:10.3390/toxins11030136 · Cited by 82
“Moreover, they activate adhesion receptors, such as the fibrin-binding platelet receptor αIIbβ3, which eventually mediates firm attachment to the fibrin clot and its contraction [64,65,103].”
Background
Metadata
- Authors
- Gale, A. J.
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2010-11-30
- Volume
- 39
- Issue
- 1
- Pages
- 273-280
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2117996963
- Cited by
- 376
- References
- 49
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.